(PharmaNewsWire.Com, May 09, 2017 ) Rabies is a condition that causes thousands of deaths worldwide every year. Humans contract rabies when bitten by an animal infected with the rabies virus. The virus is transmitted when the saliva of the infected animal touches an open wound or mucous membrane. It infects the brain and ultimately leads to death.
Publisher's analysts forecast the global rabies treatment market to grow at a CAGR of 4.91% during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-rabies-treatment-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global rabies treatment market for 2017-2021. To calculate the market size, the report considers the rabies vaccine sales for both human and animal usage.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
